These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37743699)

  • 21. Painful or Mild-Pain Constipation? A Clinically Useful Alternative to Classification as Irritable Bowel Syndrome with Constipation Versus Functional Constipation.
    Bouchoucha M; Devroede G; Mary F; Bon C; Bejou B; Benamouzig R
    Dig Dis Sci; 2018 Jul; 63(7):1763-1773. PubMed ID: 29492744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical features, quality of life and psychological health of patients with irritable bowel syndrome and functional dyspepsia].
    Yi ZH; Yang ZB; Kang L; Feng L; Yang L
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):493-6. PubMed ID: 24941826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-enteric neuronal antibodies and the irritable bowel syndrome.
    Wood JD; Liu S; Drossman DA; Ringel Y; Whitehead WE
    J Neurogastroenterol Motil; 2012 Jan; 18(1):78-85. PubMed ID: 22323991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of oro-cecal transit time in patients with irritable bowel syndrome with cereal products intolerance].
    Błońska A; Konrad P; Chojnacki J; Chojnacki C
    Pol Merkur Lekarski; 2017 Mar; 42(249):116-120. PubMed ID: 28333903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mixture model analysis identifies irritable bowel syndrome subgroups characterised by specific profiles of gastrointestinal, extraintestinal somatic and psychological symptoms.
    Polster A; Van Oudenhove L; Jones M; Öhman L; Törnblom H; Simrén M
    Aliment Pharmacol Ther; 2017 Sep; 46(5):529-539. PubMed ID: 28671338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying Rome symptoms for diagnosis of the irritable bowel syndrome.
    Chang JY; Almazar AE; Richard Locke G; Larson JJ; Atkinson EJ; Talley NJ; Saito YA
    Neurogastroenterol Motil; 2018 Sep; 30(9):e13356. PubMed ID: 29701271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comorbid irritable bowel syndrome symptoms and headache have greater association with anxiety than depression: Annual health check-up survey results.
    Kawashima K; Fukuba N; Uemura Y; Ota K; Kazumori H; Sonoyama H; Oka A; Tada Y; Mishima Y; Oshima N; Yuki T; Katsube T; Kinoshita Y; Ishihara S
    Medicine (Baltimore); 2020 Nov; 99(47):e23059. PubMed ID: 33217807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
    Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern.
    Su AM; Shih W; Presson AP; Chang L
    Neurogastroenterol Motil; 2014 Jan; 26(1):36-45. PubMed ID: 23991913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-sensitive C-Reactive Protein as a Marker for Inflammation in Irritable Bowel Syndrome.
    Hod K; Ringel-Kulka T; Martin CF; Maharshak N; Ringel Y
    J Clin Gastroenterol; 2016 Mar; 50(3):227-32. PubMed ID: 25930973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of, and natural history among, individuals with Rome IV functional bowel disorders.
    Goodoory VC; Houghton LA; Black CJ; Ford AC
    Neurogastroenterol Motil; 2022 May; 34(5):e14268. PubMed ID: 34532930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rome III survey of irritable bowel syndrome among ethnic Malays.
    Lee YY; Waid A; Tan HJ; Chua AS; Whitehead WE
    World J Gastroenterol; 2012 Nov; 18(44):6475-80; discussion p. 6479. PubMed ID: 23197894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin].
    Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Constipation and Constipation-predominant Irritable Bowel Syndrome: A Comparative Study Using Rome III Criteria.
    Rajindrajith S; Devanarayana NM; Benninga MA
    J Pediatr Gastroenterol Nutr; 2017 May; 64(5):679-684. PubMed ID: 27403609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
    Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
    Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subjective Taste and Smell Changes in Conjunction with Anxiety and Depression Are Associated with Symptoms in Patients with Functional Constipation and Irritable Bowel Syndrome.
    Liu J; Lv C; Wu D; Wang Y; Sun C; Cheng C; Yu Y
    Gastroenterol Res Pract; 2021; 2021():5491188. PubMed ID: 34589124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of celiac disease and related antibodies in patients diagnosed with irritable bowel syndrome according to the Rome III criteria. A case-control study.
    Sánchez-Vargas LA; Thomas-Dupont P; Torres-Aguilera M; Azamar-Jacome AA; Ramírez-Ceervanes KL; Aedo-Garcés MR; Meixueiro-Daza A; Roesch-Dietlen F; Grube-Pagola P; Vivanco-Cid H; Remes-Troche JM
    Neurogastroenterol Motil; 2016 Jul; 28(7):994-1000. PubMed ID: 26914655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of abuse and mood on bowel symptoms and health-related quality of life in irritable bowel syndrome (IBS).
    Kanuri N; Cassell B; Bruce SE; White KS; Gott BM; Gyawali CP; Sayuk GS
    Neurogastroenterol Motil; 2016 Oct; 28(10):1508-17. PubMed ID: 27151081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.